EGFR mutation and response of lung cancer to gefitinib.

作者: Shinichi Toyooka , Katsuyuki Kiura , Tetsuya Mitsudomi , None

DOI: 10.1056/NEJM200505193522019

关键词: CarcinomaDrug resistanceLung cancerOncologyGenotypePoint mutationInternal medicineMEDLINEMedicineGefitinibText mining

摘要: … EGFR sensitivity mutations. In addition, detecting T790M may be useful for predicting pretreatment resistance to EGFR … the role of EGFR mutations in the development of EGFR-related …

参考文章(5)
Catherine Roche-Lestienne, Jean-Luc Laï, Stéphane Darré, Thierry Facon, Claude Preudhomme, A mutation conferring resistance to imatinib at the time of diagnosis of chronic myelogenous leukemia. The New England Journal of Medicine. ,vol. 348, pp. 2265- 2266 ,(2003) , 10.1056/NEJMC035089
William Pao, Vincent A Miller, Katerina A Politi, Gregory J Riely, Romel Somwar, Maureen F Zakowski, Mark G Kris, Harold Varmus, Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain PLoS Medicine. ,vol. 2, pp. e73- ,(2005) , 10.1371/JOURNAL.PMED.0020073
Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, Pasi A. Jänne, Olivier Kocher, Matthew Meyerson, Bruce E. Johnson, Michael J. Eck, Daniel G. Tenen, Balázs Halmos, EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib The New England Journal of Medicine. ,vol. 352, pp. 786- 792 ,(2005) , 10.1056/NEJMOA044238
Catherine Roche-Lestienne, Valerie Soenen-Cornu, Nathalie Grardel-Duflos, Jean-Luc Laı̈, Nathalie Philippe, Thierry Facon, Pierre Fenaux, Claude Preudhomme, Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment Blood. ,vol. 100, pp. 1014- 1018 ,(2002) , 10.1182/BLOOD.V100.3.1014
Takayuki Kosaka, Yasushi Yatabe, Hideki Endoh, Hiroyuki Kuwano, Takashi Takahashi, Tetsuya Mitsudomi, Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer Cancer Research. ,vol. 64, pp. 8919- 8923 ,(2004) , 10.1158/0008-5472.CAN-04-2818